Synonyms:lifirafenib, BGB-283, 1446090-77-2, 1446090-79-4, Beigene-283, 5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one, Bgb 283, UNII-8762XZS5ZF, 8762XZS5ZF, 5-(((1R,1aS,6bR)-1-(6-(Trifluoromethyl)-1H-benzimidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-1H-1,8-naphthyridin-2-one, BGB283, 5-({(1r,1as,6br)-1-[5-(Trifluoromethyl)-1h-Benzimidazol-2-Yl]-1a,6b-Dihydro-1h-Cyclopropa[b][1]benzofuran-5-Yl}oxy)-3,4-Dihydro-1,8-Naphthyridin-2(1h)-One, 5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one, compound 2.2b, 5-{{(1r,1as,6br)-1-[5-(trifluoromethyl)-1h-benzimidazol-2-yl]-1a,6b-dihydro-1h-cyclopropa[b][1]benzofuran-5-yl}oxy}-3,4-dihydro-1,8-naphthyridin-2(1h)-one, Lifirafenib [USAN], Lifirafenib (USAN/INN), BGB-283;Beigene-283, GTPL8958, CHEMBL4209157, SCHEMBL15085288, BDBM372968, EX-A1473, US9895376, Compound 2.2b, WHC09077, WHC09079, Lifirafenib;BGB-283;Beigene-283, BDBM50453816, WHO 10554, ZINC68764621, CS-6308, DB14773, HY-18957, D11410, A900647, Q27075193, 1,8-Naphthyridin-2(1H)-one, 5-(((1R,1aS,6bR)-1a,6b-dihydro-1-(6-(trifluoromethyl)-1H-benzimidazol-2-yl)-1H-cyclopropa(b)benzofuran-5-yl)oxy)-3,4-dihydro-, 3K3
Pubchem:PUBCHEM:89670174
Id:ce5056b4-b3ae-56f9-a1eb-14053c3c6425
Description:nan